<?xml version="1.0" encoding="utf-8" standalone="no"?><Article><ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" OutputMedium="All" TocLevels="0"><ArticleID>ACER&#x002D;D&#x002D;18&#x002D;00543</ArticleID><ArticleDOI><?InsertOnReleaseDOI DOI?></ArticleDOI><ArticleSequenceNumber>0</ArticleSequenceNumber><ArticleTitle Language="En"><Annotation ID="1" Text="The English Abstract for the given article is missing in the Manuscript. Please check." />Association of Uric Acid with Stenosis of Intracranial and Extracranial Arteries in Elderly Patients with Cerebral Infarction</ArticleTitle><ArticleCategory>OriginalPaper</ArticleCategory><ArticleFirstPage>1</ArticleFirstPage><ArticleLastPage>1</ArticleLastPage><ArticleHistory><RegistrationDate><Year><?InsertOnReleaseYear OnlineYear?></Year><Month><?InsertOnReleaseMonth OnlineMonth?></Month><Day><?InsertOnReleaseDay OnlineDay?></Day></RegistrationDate><OnlineDate><Year><?InsertOnReleaseYear OnlineYear?></Year><Month><?InsertOnReleaseMonth OnlineMonth?></Month><Day><?InsertOnReleaseDay OnlineDay?></Day></OnlineDate></ArticleHistory><ArticleCopyright><CopyrightHolderName><?InsertOnReleaseOnlineCopyrightName CopyrightName?></CopyrightHolderName><CopyrightYear>2018</CopyrightYear></ArticleCopyright><ArticleContext><JournalID>11103</JournalID><VolumeIDStart><?InsertOnReleaseVolumeIDStart VolumeIDStart?></VolumeIDStart><VolumeIDEnd><?InsertOnReleaseVolumeIDEnd VolumeIDEnd?></VolumeIDEnd><IssueIDStart><?InsertOnReleaseIssueIDStart IssueIDStart?></IssueIDStart><IssueIDEnd><?InsertOnReleaseIssueIDEnd IssueIDEnd?></IssueIDEnd></ArticleContext></ArticleInfo><Para ID="Par1">AUTHOUR:</Para><AuthorGroup><Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1" ID="Au1"><AuthorName><GivenName>Li</GivenName><FamilyName>Mimi</FamilyName></AuthorName><Contact><Email>277232925@qq.com</Email></Contact></Author><Author AffiliationIDS="Aff1" ID="Au2"><AuthorName><GivenName>Huang</GivenName><FamilyName>Yinhui</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1" ID="Au3"><AuthorName><GivenName>Chen</GivenName><FamilyName>Yafang</FamilyName></AuthorName></Author><Affiliation ID="Aff1"><OrgName>Institute:the neurology department of The Second Affiliated Hospital of Fujian Medical University</OrgName><OrgAddress><Street>Zhongshan North Road 34</Street><Postcode>362000</Postcode><City>Quanzhou City</City><State>Fujian Province</State><Country>P.R.China Tel:15980235819</Country></OrgAddress></Affiliation></AuthorGroup><RawAuthorGroup><Para ID="Par2">LI MIMI</Para><Para ID="Par3">INSTITUTE:THE NEUROLOGY DEPARTMENT OF THE SECOND AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIVERSITY</Para><Para ID="Par4">HUANG YINHUI</Para><Para ID="Par5">INSTITUTE:THE NEUROLOGY DEPARTMENT OF THE HOSPITAL OF JINJIANG CITY</Para><Para ID="Par6">CHEN YAFANG</Para><Para ID="Par7">INSTITUTE:THE NEUROLOGY DEPARTMENT OF THE SECOND AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIVERSITY</Para><Para ID="Par8">CORRESPONDING AUTHOR:</Para><Para ID="Par9">LI MIMI</Para><Para ID="Par10">INSTITUTE:THE NEUROLOGY DEPARTMENT OF THE SECOND AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIVERSITY</Para><Para ID="Par11">ADDRESS:ZHONGSHAN NORTH ROAD 34, QUANZHOU CITY ,FUJIAN PROVINCE 362000,P.R.CHINA</Para><Para ID="Par12">TEL:15980235819</Para><Para ID="Par13">E&#x002D;MAIL:277232925@QQ.COM</Para></RawAuthorGroup><Para ID="Par14"><Emphasis Type="Bold">Association of Uric Acid with Stenosis of Intracranial and Extracranial Arteries in Elderly Patients with Cerebral Infarction</Emphasis></Para><Para ID="Par15"><Emphasis Type="Bold">SUMMARY</Emphasis></Para><Para ID="Par16"><Emphasis Type="Bold">Background</Emphasis>: TO DETERMINE THE CORRELATION OF URIC ACID&#x0F08;UA&#x0F09;WITH INTRACRANIAL AND EXTRACRANIAL ATHEROSCLEROSIS STENOSIS OF HAN POPULATION ELDERLY PATIENTS SUFFERING FROM CEREBRAL INFARCTION IN THE CITY OF QUANZHOU IN FUJIAN.</Para><Para ID="Par17"><Emphasis Type="Bold">Methods</Emphasis>: FOR THIS STUDY, WE ENROLLED ELDERLY PATIENTS WITH CEREBRAL INFARCTION BETWEEN OCTOBER 2015 AND DECEMBER 2017&#x00A0;AT THE NEUROLOGY DEPARTMENT OF THE SECOND AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIVERSITY. ALL PATIENTS WERE EXAMINED BY COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA). PAST MEDICAL HISTORY, DEMOGRAPHIC DATA, AND BIOCHEMICAL MARKERS WERE COLLECTED. MULTIPLE LOGISTIC REGRESSION ANALYSIS WAS USED TO STUDY THE ASSOCIATION BETWEEN URIC ACID AND CEREBRAL ATHEROSCLEROSIS STENOSIS.</Para><Para ID="Par18"><UnorderedList Mark="Bullet"><ItemContent><Para ID="Par19"><Emphasis Type="Bold">Results</Emphasis>: A TOTAL OF 408 PATIENTS WERE ENROLLED IN THE STUDY AND DIVIDED INTO THE ELDER GROUP(N&#x2009;=&#x2009;196)AND THE YOUNG AND MIDDLE&#x002D;AGED GROUP(N&#x2009;=&#x2009;212). IN OLD STROKE PATIENTS,72CASES (36.73&#x0025;) WERE CLASSIFIED AS THE INTRACRANIAL ATHEROSCLEROSIS STENOSIS (ICAS) GROUP, 45CASES (22.96&#x0025;) AS THE COMBINED INTRACRANIAL AND EXTRACRANIAL ATHEROSCLEROSIS STENOSIS (COAS) GROUP, 21CASES (10.71&#x0025;) AS THE EXTRACRANIAL ATHEROSCLEROSIS STENOSIS (ECAS) GROUP, AND 58CASES (29.59&#x0025;) AS THE NON&#x002D;CEREBRAL ATHEROSCLEROSIS STENOSIS (NCAS) GROUP. COMPARED WITH THE NCAS GROUP, URIC ACID WAS SIGNIFICANTLY HIGHER (P&#x2009;=&#x2009;0.033)IN THE ICAS GROUP,COMPARED WITH THE GROUP WHICH HAD ONLY ONE STENOSIS ARTERY, URIC ACID WAS HIGHER IN THE ADVANCED STENOSIS GROUP (P&#x2009;&#x003C;&#x2009;0.001),THE MULTIPLE LOGISTIC REGRESSION ANALYSES SHOWED THAT URIC ACID WAS AN INDEPENDENT RISK FACTOR FOR INTRACRANIAL STENOSIS OF ELDERLY PATIENTS&#x0F08;OR&#x2009;=&#x2009;1.003,P&#x2009;=&#x2009;0,042),BUT THE RELATIONSHIP BETWEEN EXTRACRANIAL ARTERY STENOSIS AND URIC ACID WAS NEGATIVE.</Para></ItemContent></UnorderedList></Para><Para ID="Par20"><Emphasis Type="Bold">Conclusions</Emphasis>: THE ELEVATED URIC ACID LEVEL CORRELATES WITH INTRACRANIAL ARTERY STENOSIS AND IT IS AN UNDERLYING INDEPENDENT RISK FACTOR OF INTRACRANIAL ARTERY STENOSIS IN ELDERLY PATIENTS WITH CEREBRAL INFARCTION .</Para><KeywordGroup Language="En" OutputMedium="All"><Heading> Keywords:</Heading><Keyword>atherosclerotic</Keyword><Keyword>cerebral infarction</Keyword><Keyword>arterial stenosis&#x0F1B;uric acid</Keyword></KeywordGroup><Bodystart></Bodystart><Section1 ID="Sec1" OutputMedium="All"><Heading> INTRODUCTION</Heading><Para ID="Par21"><UnorderedList Mark="Bullet"><ItemContent><Para ID="Par22">WITH THE DEVELOPMENT OF THE SOCIETY, ISCHEMIC STROKE IS ONE OF THE MOST COMMON CAUSE OF DEATH AND A LEADING CAUSE OF DISABILITY AMONG OLD PEOPLE,STENOSIS OF INTRACRANIAL AND EXTRACRANIAL ARTERIES IS NOT ONLY THE PATHOLOGICAL FOUNDATION OF CEREBRAL INFARCTION, BUT ALSO THE COMMON REASON<Superscript>[1] [2]</Superscript>.THE CORRELATION BETWEEN URIC ACID (UA)AND CARDIOVASCULAR DISEASE IS STILL DISPUTED<Superscript>[3][4]</Superscript>. FEW STUDIES EXIST THAT HAVE INVESTIGATED THE CORRELATION BETWEEN URIC ACID AND STENOSIS OF INTRACRANIAL AND EXTRACRANIAL ARTERIES. THIS STUDY WAS PERFORMED TO EVALUATE THE FREQUENCY OF STENO&#x002D;OCCLUSIVE INTRACRANIAL AND EXTRACRANIAL ARTERIES IN ISCHEMIC STROKE ELDERLY PATIENTS AND COMPARE THE SERUM LEVELS OF URIC ACID WITH ISCHEMIC STROKE WITH ICAS, ECAS, AND NCAS AMONG ELDERLY PATIENTS .</Para></ItemContent></UnorderedList></Para></Section1><Section1 ID="Sec2" OutputMedium="All"><Heading> MATERIALS AND METHODS</Heading><Para ID="Par23"><UnorderedList Mark="Bullet"><ItemContent><Para ID="Par24"><Emphasis Type="Bold">Study subject</Emphasis></Para></ItemContent><ItemContent><Para ID="Par25">WE RETROSPECTIVELY RECRUITED CONSECUTIVE PATIENTS WITH ACUTE ISCHEMIC STROKE WHO UNDERWENT CT ANGIOGRAPHY WITH RELEVANT NEUROIMAGING FINDINGS FROM OCTOBER 2015 THROUGH DECEMBER 2017&#x00A0;AT THE NEUROLOGY DEPARTMENT OF THE SECOND AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIVERSITY. PATIENTS WERE CLASSIFIED INTO FOUR GROUPS BASED ON THEIR VASCULAR IMAGING AS FOLLOWS: 1) INTRACRANIAL STENOSIS ATHEROSCLEROSIS (ICAS) GROUP, 2) COMBINED INTRACRANIAL AND EXTRACRANIAL ATHEROSCLEROSIS STENOSIS (COAS) GROUP, 3) EXTRACRANIAL CAROTID STENOSIS ATHEROSCLEROSIS (ECAS) GROUP, 4) NON&#x002D;CEREBRAL STENOSIS ATHEROSCLEROSIS (NCAS) GROUP. THE ELDER GROUP INCLUDED PATIENTS OLDER THAN 60 YEARS,THE YOUNG AND MIDDLE&#x002D;AGED GROUP INCLUDED PATIENTS YOUNGER THAN 60&#x00A0;YEARS. WE COLLECTED DATA ON CLINICAL INFORMATION, DEMOGRAPHICS, AND BIOCHEMICAL INDICES.</Para></ItemContent><ItemContent><Para ID="Par26">SUBJECT INCLUSION CRITERIA: &#x0F08;1&#x0F09;PATIENTS WITH CEREBRAL INFARCTION WHO WERE MATCHED WITH THE 2010 GUIDELINES FOR THE CHINESE DIAGNOSIS AND TREATMENT OF ACUTE ISCHEMIC STROKE<Superscript>[5]</Superscript>.&#x0F08;2&#x0F09;AGE&#x2009;&#x003E;&#x2009;18; (3) EXAMINED BY CTA.</Para></ItemContent><ItemContent><Para ID="Par27">SUBJECT EXCLUSION CRITERIA: (1) AGE&#x2009;&#x2264;&#x2009;L8; (2) NEUROIMAGING AND LABORATORY INFORMATION WAS INCOMPLETE (3)HAD DRUGS AFFECTING URIC ACID METABOLISM USE IN 3 MONTHS.(FOR EXAMPLE, DIURETICS, ANTI&#x002D;GOUT DRUG) (4) STROKE OF OTHER DETERMINED ETIOLOGIES (RHEUMATIC HEART DISEASE, ATRIAL FIBRILLATION, ACUTE CORONARY SYNDROME, PATENT FORAMEN OVALE, SUBACUTE ARTERIAL ENDOCARDITIS, MOYAMOYA DISEASE, ARTERIOVENOUS MALFORMATION, SYPHILITICA VASCULITIS, IMMUNE VASCULITIS, ARTERY DISSECTION, RADIATION STENOSIS, BLOOD DISEASE, SUBSTANCE ABUSE AND SO ON).</Para></ItemContent><ItemContent><Para ID="Par28">DEFINITION OF RISK FACTORS: (1) HYPERTENSION: HYPERTENSION WAS DEFINED AS SYSTOLIC BLOOD PRESSURE&#x2009;&#x2265;&#x2009;140&#x00A0;MMHG AND/OR DIASTOLIC BLOOD PRESSURE&#x2009;&#x2265;&#x2009;90&#x00A0;MMHG DURING THE 7 DAYS AFTER STROKE ON DIFFERENT DAYS MORE THAN 3 TIMES OR A HISTORY OF PHYSICIAN DIAGNOSIS OF HYPERTENSION. (2) DIABETES MELLITUS: THE PATIENTS FIT ONE OF THE FOLLOWERING: 1) SYMPTOM OF DIABETES MELLITUS AND RANDOM PLASMA GLUCOSE&#x2009;&#x2265;&#x2009;11.1&#x00A0;MMOL/L; 2) SYMPTOMS OF DIABETES MELLITUS AND FASTING BLOOD GLUCOSE&#x2009;&#x2265;&#x2009;7.0&#x00A0;MMOL/L; 3) SYMPTOM OF DIABETES MELLITUS AND BLOOD GLUCOSE OF THE 2 HOUR OGTT&#x2009;&#x2265;&#x2009;11.1&#x00A0;MMOL/L; OR A HISTORY OF DIABETES MELLITUS; (3) SMOKING: PATIENTS HAD MORE THAN FIVE CIGARETTES FOR MORE THAN TWELVE MONTHS AND DID NOT GIVE UP SMOKING OR HAVE GIVEN UP SMOKING FOR LESS THAN 6 MONTHS.</Para></ItemContent><ItemContent><Para ID="Par29">THE STUDY WAS APPROVED BY THE ETHICS COMMITTEES OF:SECOND AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIVERSITY,QUANZHOU, FUJIAN PROVINCE, CHINA. PATIENTS OR THEIR FAMILYMEMBERS PROVIDED WRITTEN INFORMED CONSENT.</Para></ItemContent></UnorderedList></Para><Para ID="Par30"><Emphasis Type="Bold">Definition on Stenosis of Intracranial and Extracranial Arteries</Emphasis></Para><Para ID="Par31"><UnorderedList Mark="Bullet"><ItemContent><Para ID="Par32">THE EXTRACRANIAL ARTERIES INCLUDED THE CAROTID ARTERY (CCA), EXTERNAL CAROTID ARTERY (ECA), THE EXTRACRANIAL PORTION OF INTERNAL CAROTID ARTERY (E&#x002D;ICA) (C1), THE EXTRACRANIAL PORTION OF VERTEBRAL ARTERY (V1&#x002D;V3), AND THE SUBCLAVIAN ARTERY (SCA). THE INTRACRANIAL ARTERIES INCLUDED THE INTRACRANIAL PORTION OF THE CAROTID ARTERY (I&#x002D;ICA) (C4&#x002D;C7), MIDDLE CEREBRAL ARTERY (MCA), ANTERIOR CEREBRAL ARTERY (ACA), POSTERIOR CEREBRAL ARTERY (PCA), INTRACRANIAL PORTION OF VERTEBRAL ARTERY (I&#x002D;VA) (V4), AND BASILAR ARTERY (BA).</Para></ItemContent></UnorderedList></Para><Para ID="Par33"><Emphasis Type="Bold">The Main Checking Method</Emphasis></Para><Para ID="Par34"><Emphasis Type="Bold">Blood Tests</Emphasis></Para><Para ID="Par35"><UnorderedList Mark="Bullet"><ItemContent><Para ID="Par36">BLOOD SAMPLES FOR FASTING CONCENTRATIONS WERE DRAWN IN THE MORNING WITHIN 24 HOURS; SERUM LEVELS OF TOTAL CHOLESTEROL(TC), TRIGLYCERIDE(TG), HIGH&#x002D;DENSITY LIPOPROTEIN CHOLESTEROL(HDL&#x002D;C),UA ,LOW&#x002D;DENSITY LIPOPROTEIN CHOLESTEROL(LDL&#x002D;C) FIBRINOGEN(FIB),HEMOGLOBIN A1C(HBALC)AND HOMOCYSTEINE(HCY) WERE ANALYSED USING A BECKMAN AU680 CHEMISTRY SYSTEM AND A BECKMAN LH 780 HAEMATOLOGY ANALYSER ACCORDING TO THE MANUFACTURER&#x2019;S INSTRUCTIONS (BECKMAN COULTER, BREA, CA, USA).</Para></ItemContent><ItemContent><Para ID="Par37">COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA)</Para></ItemContent><ItemContent><Para ID="Par38">CTA WAS DONE USING A 64&#x002D;SLICE DOUBLE SOURCE CT FROM SIEMENS AG EXCEPT HEMORRHAGIC CEREBROVASCULAR DISEASE. AFTER CONVENTIONAL CROSS&#x002D;SECTIONAL SCANNING, WE FINISHED THE HEAD AND NECK SCANNING WITH BOLUS INJECTION OF IOPAMIDOL (300MGI/ML) BY HIGH PRESSURE INJECTOR THROUGH THE RADIAL VEIN AT THE RATE OF 4&#x2013;5&#x00A0;ML/S. THE SCANNING RANGE: 7TH CERVICAL VERTEBRAE TO BASIS CRANII. REAL&#x002D;TIME MONITORING AFTER INJECTION, WE SCANNED AT THE PEAK VALUE OF CONTRAST MEDIUM. WE INVESTIGATED STENOSIS OF INTRACRANIAL AND EXTRACRANIAL ARTERIES THROUGH THE IMAGE RECONSTRUCTED BY MAXIMUM INTENSITY PROJECTION AND VOLUME RENDERING.THE WAY OF RECONSTRUCTION: SURFACE&#x002D;SHADED DISPLAY, VOLUME RENDERING, SURFACE RECONSTRUCTION.ALL IMAGES WERE READ BY TWO NEUROIMAGING EXPERTS.</Para></ItemContent></UnorderedList></Para><Section2 ID="Sec3" OutputMedium="All"><Heading>Statistical Analysis</Heading><Para ID="Par39"><UnorderedList Mark="Bullet"><ItemContent><Para ID="Par40">FOR STATISTICAL ANALYSIS, SOFTWARE VERSION SPSS20.0 WAS USED (SPSS INC., USA). DATA WERE SUMMARIZED AS MEAN&#x2009;&#x00B1;&#x2009;SD OR SE OR NUMBER OF SUBJECTS (PERCENTAGE), AS APPROPRIATE. COMPARISONS ACROSS GROUPS WERE EXAMINED USING THE CHI&#x002D;SQUARE TEST FOR CATEGORICAL VARIABLES AND STUDENT&#x2019;S T&#x002D;TEST OR ONE&#x002D;WAY ANALYSIS OF VARIANCE FOLLOWED BY THE TURKEY&#x2019;S B TEST FOR MULTIPLE COMPARISONS FOR CONTINUOUS VARIABLES. A MULTIVARIABLE LOGISTIC REGRESSION ANALYSIS WAS PERFORMED TO FIND THE INDEPENDENT PREDICTOR OF ICAS OR ECAS. RESULTS WERE GIVEN BY ORS AND THEIR 95&#x0025; CIS. P&#x2009;&#x003C;&#x2009;0.05 WAS CONSIDERED STATISTICALLY SIGNIFICANT. ALL TESTS WERE TWO&#x002D;TAILED.</Para></ItemContent></UnorderedList></Para></Section2></Section1><Section1 ID="Sec4" Type="Results" OutputMedium="All"><Heading>RESULTS</Heading><Para ID="Par41">196 elderly patients were included in this study,212young and middle&#x002D;aged patients at the same time, altogether 408 patients. The old stroke patients had a mean&#x2009;&#x00B1;&#x2009;SD age of 72.73&#x2009;&#x00B1;&#x2009;5.37 years,(range 65&#x2013;89&#x00A0;years) and 120 were male.</Para><Para ID="Par42"><Emphasis Type="Bold">Distribution of Stenosis of Intracranial and Extracranial Arteries</Emphasis></Para><Para ID="Par43">In old patients,72(36.73&#x0025;) were classified as ICAS, 45 (22.96&#x0025;) as COAS, 21 (10.71&#x0025;) as ECAS, and 58 (29.59&#x0025;) as NCAS.In young and middle&#x002D;aged patients,64(30.19&#x0025;) were classified as ICAS, 28 (13.21&#x0025;) as COAS, 24 (11.32&#x0025;) as ECAS, and 96(45.58&#x0025;) as NCAS. Compared with young and middle&#x002D;aged patients,cerebral artery stenoses often happen in old people,especially intracranial artery stenoses,(Fig.&#x00A0;<InternalRef RefID="Fig1">1</InternalRef>).</Para><Para ID="Par44">The proportion of old patients with different numbers of stenoses of intracranial arteries was as follows: 53(27.04&#x0025;) of one artery, 35 (17.18&#x0025;) of two arteries, 29 (14.80&#x0025;) of three or more arteries.</Para><Para ID="Par45">The proportion of old patients with different numbers of stenoses of extracranial arteries was as follows: 41 (20.92&#x0025;) of one artery, 15 (7.65&#x0025;) of two arteries, 9 (4.59&#x0025;) of three or more arteries.</Para><Para ID="Par46"><Figure Category="Standard" Float="Yes" ID="Fig1"><Caption Language="En"><CaptionNumber>Fig. 1</CaptionNumber><CaptionContent><SimplePara>Distribution of stenoses of intracranial and extracranial arteries in different age</SimplePara></CaptionContent></Caption><MediaObject><ImageObject FileRef="float_image1.jpeg" Format="JPEG" Color="BlackWhite" Type="Linedraw" Rendition="HTML" /></MediaObject></Figure></Para><Para ID="Par47"><Emphasis Type="Bold">Single Factor Analysis</Emphasis></Para><SpListbullet1><ItemNumber></ItemNumber><ItemContent><Para ID="Par48">IN OLD PATIENTS,COMPARED WITH NCAS, ICAS GROUP SHOWED SIGNIFICANTLY HIGHER FREQUENCIES OF MALE&#x0F08;P&#x2009;=&#x2009;0.033,X2&#x2009;=&#x2009;4.76&#x0F09;.ICAS, ECAS, AND COAS GROUPS SHOWED SIGNIFICANTLY HIGHER LEVELS OF LDL&#x002D;C(P&#x2009;=&#x2009;0.048,P&#x2009;=&#x2009;0.015 AND 0.002,RESPECTIVELY),TC WAS SIGNIFICANTLY HIGHER IN THE ICAS GROUP AND COAS GROUP (P&#x2009;=&#x2009;0.02 AND P&#x2009;=&#x2009;0.08, RESPECTIVELY),UA WAS SIGNIFICANTLY HIGHER IN THE ICAS GROUP AND COAS GROUP (P&#x2009;=&#x2009;0.033 AND P&#x2009;=&#x2009;0.018, RESPECTIVELY)., BUT OTHER CHARACTERISTICS WERE NOT SIGNIFICANTLY DIFFERENT ,(Table&#x00A0;<InternalRef RefID="Tab1">1</InternalRef>).</Para></ItemContent></SpListbullet1><SpListbullet1><ItemNumber></ItemNumber><ItemContent><Para ID="Par49">*p&#x2009;&#x003C;&#x2009;0.05vsNCAS</Para></ItemContent></SpListbullet1><SpListbullet1><ItemNumber></ItemNumber><ItemContent><Para ID="Par50">DIVIDED UA INTO QUARTERS&#x0F08;1ST&#x2009;&#x2264;&#x2009;261.2&#x00A0;&#x039C;MOL/L&#x0F1B;261.2&#x00A0;&#x039C;MOL/L&#x0F1C;2ND&#x2009;&#x2264;&#x2009;321.9&#x00A0;&#x039C;MOL/L&#x0F1B;321.9&#x00A0;&#x039C;MOL/L&#x0F1C;3RD&#x2009;&#x2264;&#x2009;388.8&#x00A0;&#x039C;MOL/L&#x0F1B;4TH&#x0F1E;388.8&#x00A0;&#x039C;MOL/L&#x0F09;.WHERE THE HIGHER THE LEVEL OF UA, THE HIGHER THE PERCENTAGE OF CEREBRAL ATHEROSCLEROSIS STENOSIS(X2&#x2009;=&#x2009;9.231,P&#x2009;=&#x2009;0.024&#x0F09;,(FIG.&#x00A0;<InternalRef RefID="Fig2">2</InternalRef>).</Para></ItemContent></SpListbullet1><SpListbullet1><ItemNumber></ItemNumber><ItemContent><Para ID="Par51"></Para></ItemContent></SpListbullet1><Para ID="Par52"><Table Float="Yes" ID="Tab1"><Caption Language="En"><CaptionNumber>Table 1</CaptionNumber><CaptionContent><SimplePara>Baseline characteristics among groups</SimplePara></CaptionContent></Caption><tgroup cols="5"><colspec colnum="1" colname="c1" align="left" /><colspec colnum="2" colname="c2" align="left" /><colspec colnum="3" colname="c3" align="left" /><colspec colnum="4" colname="c4" align="left" /><colspec colnum="5" colname="c5" align="left" /><thead><row><entry align="left" colname="c1" morerows="1"><SimplePara>Clinical</SimplePara><SimplePara><Emphasis Type="Bold">characteristics</Emphasis></SimplePara></entry><entry align="left" colname="c2"><SimplePara>ICAS</SimplePara></entry><entry align="left" colname="c3"><SimplePara>ECAS</SimplePara></entry><entry align="left" colname="c4"><SimplePara>COAS</SimplePara></entry><entry align="left" colname="c5"><SimplePara>NOCS</SimplePara></entry></row><row><entry align="left" colname="c2"><SimplePara><Emphasis Type="Bold">n&#x2009;=&#x2009;72</Emphasis></SimplePara></entry><entry align="left" colname="c3"><SimplePara><Emphasis Type="Bold">n&#x2009;=&#x2009;21</Emphasis></SimplePara></entry><entry align="left" colname="c4"><SimplePara><Emphasis Type="Bold">n&#x2009;=&#x2009;45</Emphasis></SimplePara></entry><entry align="left" colname="c5"><SimplePara><Emphasis Type="Bold">n&#x2009;=&#x2009;58</Emphasis></SimplePara></entry></row></thead><tbody><row><entry align="left" colname="c1"><SimplePara>Age(years)</SimplePara></entry><entry align="left" colname="c2"><SimplePara>72.15&#x2009;&#x00B1;&#x2009;5.73</SimplePara></entry><entry align="left" colname="c3"><SimplePara>74.19&#x2009;&#x00B1;&#x2009;4.81</SimplePara></entry><entry align="left" colname="c4"><SimplePara>72.18&#x2009;&#x00B1;&#x2009;5.22</SimplePara></entry><entry align="left" colname="c5"><SimplePara>73.34&#x2009;&#x00B1;&#x2009;5.59</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>TC(mmol/L)</SimplePara></entry><entry align="left" colname="c2"><SimplePara>4.98&#x2009;&#x00B1;&#x2009;1.11</SimplePara></entry><entry align="left" colname="c3"><SimplePara>5.36&#x2009;&#x00B1;&#x2009;1.00*</SimplePara></entry><entry align="left" colname="c4"><SimplePara>5.28&#x2009;&#x00B1;&#x2009;1.15*</SimplePara></entry><entry align="left" colname="c5"><SimplePara>4.63&#x2009;&#x00B1;&#x2009;1.26</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>TG&#x0F08;mmol/L)</SimplePara></entry><entry align="left" colname="c2"><SimplePara>1.49&#x2009;&#x00B1;&#x2009;0.70</SimplePara></entry><entry align="left" colname="c3"><SimplePara>1.44&#x2009;&#x00B1;&#x2009;0.71</SimplePara></entry><entry align="left" colname="c4"><SimplePara>1.45&#x2009;&#x00B1;&#x2009;0.86</SimplePara></entry><entry align="left" colname="c5"><SimplePara>1.43&#x2009;&#x00B1;&#x2009;1.00</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>HDL&#x002D;C(mmol/L)</SimplePara></entry><entry align="left" colname="c2"><SimplePara>1.14&#x2009;&#x00B1;&#x2009;0.30</SimplePara></entry><entry align="left" colname="c3"><SimplePara>1.28&#x2009;&#x00B1;&#x2009;0.30</SimplePara></entry><entry align="left" colname="c4"><SimplePara>1.16&#x2009;&#x00B1;&#x2009;0.33</SimplePara></entry><entry align="left" colname="c5"><SimplePara>1.21&#x2009;&#x00B1;&#x2009;0.30</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>LDL&#x002D;C(mmol/L)</SimplePara></entry><entry align="left" colname="c2"><SimplePara>3.20&#x2009;&#x00B1;&#x2009;0.86</SimplePara></entry><entry align="left" colname="c3"><SimplePara>3.31&#x2009;&#x00B1;&#x2009;0.73*</SimplePara></entry><entry align="left" colname="c4"><SimplePara>3.37&#x2009;&#x00B1;&#x2009;0.87*</SimplePara></entry><entry align="left" colname="c5"><SimplePara>2.71&#x2009;&#x00B1;&#x2009;0.90</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>UA(&#x00B5;mol/L)</SimplePara></entry><entry align="left" colname="c2"><SimplePara>340.59&#x2009;&#x00B1;&#x2009;91.83*</SimplePara></entry><entry align="left" colname="c3"><SimplePara>341.09&#x2009;&#x00B1;&#x2009;83.17</SimplePara></entry><entry align="left" colname="c4"><SimplePara>350.56&#x2009;&#x00B1;&#x2009;93.77*</SimplePara></entry><entry align="left" colname="c5"><SimplePara>304.34&#x2009;&#x00B1;&#x2009;99.34</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Glycosylated hemoglobin(&#x0025;)</SimplePara></entry><entry align="left" colname="c2"><SimplePara>6.13&#x2009;&#x00B1;&#x2009;2.69</SimplePara></entry><entry align="left" colname="c3"><SimplePara>5.94&#x2009;&#x00B1;&#x2009;2.46</SimplePara></entry><entry align="left" colname="c4"><SimplePara>5.36&#x2009;&#x00B1;&#x2009;3.14</SimplePara></entry><entry align="left" colname="c5"><SimplePara>6.17&#x2009;&#x00B1;&#x2009;2.41</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>HCY(&#x00B5;mol/L)</SimplePara></entry><entry align="left" colname="c2"><SimplePara>11.92&#x2009;&#x00B1;&#x2009;6.63</SimplePara></entry><entry align="left" colname="c3"><SimplePara>10.16&#x2009;&#x00B1;&#x2009;3.49</SimplePara></entry><entry align="left" colname="c4"><SimplePara>11.54&#x2009;&#x00B1;&#x2009;9.12</SimplePara></entry><entry align="left" colname="c5"><SimplePara>11.55&#x2009;&#x00B1;&#x2009;6.90</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Fib(g/L)</SimplePara></entry><entry align="left" colname="c2"><SimplePara>3.67&#x2009;&#x00B1;&#x2009;1.39</SimplePara></entry><entry align="left" colname="c3"><SimplePara>3.29&#x2009;&#x00B1;&#x2009;1.21</SimplePara></entry><entry align="left" colname="c4"><SimplePara>3.44&#x2009;&#x00B1;&#x2009;1.25</SimplePara></entry><entry align="left" colname="c5"><SimplePara>3.40&#x2009;&#x00B1;&#x2009;1.88</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Gender&#x0F08;male&#x0F09;</SimplePara></entry><entry align="left" colname="c2"><SimplePara>36(50.0&#x0025;&#x0F09;</SimplePara></entry><entry align="left" colname="c3"><SimplePara>13(61.9&#x0025;)</SimplePara></entry><entry align="left" colname="c4"><SimplePara>31(68.9&#x0025;)</SimplePara></entry><entry align="left" colname="c5"><SimplePara>40(69.0&#x0025;&#x0F09;</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Hypertension</SimplePara><SimplePara>(n (&#x0025;))</SimplePara></entry><entry align="left" colname="c2"><SimplePara>54(75.0&#x0025;)</SimplePara></entry><entry align="left" colname="c3"><SimplePara>11(52.4&#x0025;)</SimplePara></entry><entry align="left" colname="c4"><SimplePara>34(75.6&#x0025;)</SimplePara></entry><entry align="left" colname="c5"><SimplePara>36(62.1&#x0025;)</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Diabetes (n (&#x0025;))</SimplePara></entry><entry align="left" colname="c2"><SimplePara>25(34.7)</SimplePara></entry><entry align="left" colname="c3"><SimplePara>9(42.9&#x0025;)</SimplePara></entry><entry align="left" colname="c4"><SimplePara>14(31.1&#x0025;)</SimplePara></entry><entry align="left" colname="c5"><SimplePara>14(24.1&#x0025;)</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Smoker (n (&#x0025;))</SimplePara></entry><entry align="left" colname="c2"><SimplePara>21(29.2&#x0025;)</SimplePara></entry><entry align="left" colname="c3"><SimplePara>8(38.1&#x0025;)</SimplePara></entry><entry align="left" colname="c4"><SimplePara>18(40&#x3002;0&#x0025;)</SimplePara></entry><entry align="left" colname="c5"><SimplePara>23(39.7)</SimplePara></entry></row></tbody></tgroup></Table></Para><Para ID="Par53"><Figure Category="Standard" Float="Yes" ID="Fig2"><Caption Language="En"><CaptionNumber>Fig. 2</CaptionNumber><CaptionContent><SimplePara>Distribution of the study group according to apo A1 and apo B</SimplePara></CaptionContent></Caption><MediaObject><ImageObject FileRef="float_image2.jpeg" Format="JPEG" Color="BlackWhite" Type="Linedraw" Rendition="HTML" /></MediaObject></Figure></Para><SpListbullet1><ItemNumber></ItemNumber><ItemContent><Para ID="Par54"><Annotation ID="2" Text="Fig. 3 caption is missing. Please check" /><Annotation ID="3" Text="Fig. 4 caption is missing. Please check" />COMPARED WITH THE GROUP WHICH HAD ONLY ONE STENOSIS ARTERY, UA WAS HIGHER IN THE ADVANCED STENOSIS GROUP (P&#x0F1C;0.001) (FIG.&#x00A0;3). THE LEVEL OF UA HAD NO STATISTICAL DIFFERENCES IN DIFFERENT NUMBERS OF ECAS(FIG.&#x00A0;4).</Para></ItemContent></SpListbullet1><SpListbullet1><ItemNumber></ItemNumber><ItemContent><Para ID="Par55"><InlineMediaObject><ImageObject FileRef="float_image3.jpeg" Format="JPEG" Color="BlackWhite" Type="Linedraw" Rendition="HTML" /></InlineMediaObject><InlineMediaObject><ImageObject FileRef="float_image4.jpeg" Format="JPEG" Color="BlackWhite" Type="Linedraw" Rendition="HTML" /></InlineMediaObject></Para></ItemContent></SpListbullet1><Para ID="Par56"><Emphasis Type="Bold">Figure3</Emphasis>. Serum levels of UA according to severity of ICAS <Emphasis Type="Bold">Fig.&#x00A0;4</Emphasis>. Serum levels of UA according to severity of ECAS</Para><Para ID="Par57"><Emphasis Type="Bold">Multivariable Logistic Analysis</Emphasis></Para><Para ID="Par58"><Annotation ID="4" Text="Table 2 caption is missing. Please check" /><Annotation ID="5" Text="Table 3 caption is missing. Please check" /><UnorderedList Mark="Bullet"><ItemContent><Para ID="Par59">WE SELECTED AGE, TC, LDL&#x002D;C, UA, DIABETES MELLITUS,GENDER,HYPERTENSION, INTO MULTIVARIABLE LOGISTIC ANALYSIS. WE FOUND THAT UA WAS AN INDEPENDENT RISK FACTOR OF INTRACRANIAL STENOSIS (OR: 0.003, 95&#x0025; CI: 1.000&#x2013;1.007),(TABLE&#x00A0;2).BUT UA WAS NOT AN INDEPENDENT RISK FACTOR OF EXTRACRANIAL STENOSIS,(TABLE&#x00A0;3).</Para></ItemContent></UnorderedList></Para><Para ID="Par60">Table&#x00A0;2. Multivariate logistic regression analyses for independent clinical and demo&#x002D;</Para><Para ID="Par61">graphic risk factors for ICAS</Para><Para ID="Par62"><Table Float="No" ID="Taba"><tgroup cols="6"><colspec colnum="1" colname="c1" align="left" /><colspec colnum="2" colname="c2" align="char" char="." /><colspec colnum="3" colname="c3" align="char" char="." /><colspec colnum="4" colname="c4" align="char" char="." /><colspec colnum="5" colname="c5" align="char" char="." /><colspec colnum="6" colname="c6" align="char" char="." /><thead><row><entry align="left" colname="c1" /><entry align="left" colname="c2"><SimplePara>B</SimplePara></entry><entry align="left" colname="c3"><SimplePara>Wald</SimplePara></entry><entry align="left" colname="c4"><SimplePara>P</SimplePara></entry><entry align="left" colname="c5"><SimplePara>OR</SimplePara></entry><entry align="left" colname="c6"><SimplePara>OR(95&#x0025;CI)</SimplePara></entry></row></thead><tbody><row><entry align="left" colname="c1"><SimplePara>Age</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>&#x002D;0.04</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>2.003</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.157</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>0.961</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.909&#x2013;1.016</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>TC</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>&#x002D;0.475</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>1.156</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.282</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>0.622</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.261&#x2013;1.479</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>LDL&#x002D;C</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>0.79</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>2.122</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.145</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>2.202</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.761&#x2013;6.371</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>UA</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>0.003</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>4.116</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.042</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>1.003</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>1.000&#x002D;1.007</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Diabetes</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>&#x002D;0.024</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>0.005</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.946</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>0.977</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.492&#x2013;1.938</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Gender</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>&#x002D;0.301</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>0.713</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.399</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>0.74</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.368&#x2013;1.488</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Hypertension</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>0.653</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>3.606</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.058</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>1.922</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.979&#x2013;3.771</SimplePara></entry></row></tbody></tgroup><tfooter><SimplePara>*the control group for NCAS group and ECAS group</SimplePara></tfooter></Table></Para><Para ID="Par63">Table&#x00A0;3. Multivariate logistic regression analyses for independent clinical and demo&#x002D;</Para><Para ID="Par64">graphic risk factors for ECAS</Para><Para ID="Par65"><Table Float="No" ID="Tabb"><tgroup cols="6"><colspec colnum="1" colname="c1" align="left" /><colspec colnum="2" colname="c2" align="char" char="." /><colspec colnum="3" colname="c3" align="char" char="." /><colspec colnum="4" colname="c4" align="char" char="." /><colspec colnum="5" colname="c5" align="char" char="." /><colspec colnum="6" colname="c6" align="char" char="." /><thead><row><entry align="left" colname="c1" /><entry align="left" colname="c2"><SimplePara>B</SimplePara></entry><entry align="left" colname="c3"><SimplePara>Wald</SimplePara></entry><entry align="left" colname="c4"><SimplePara>P</SimplePara></entry><entry align="left" colname="c5"><SimplePara>OR</SimplePara></entry><entry align="left" colname="c6"><SimplePara>OR(95&#x0025;CI)</SimplePara></entry></row></thead><tbody><row><entry align="left" colname="c1"><SimplePara>Age</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>0.016</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>0.313</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.576</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>1.017</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.960&#x2013;1.077</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>TC</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>&#x002D;0.121</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>0.072</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.788</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>0.886</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.367&#x2013;2.140</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>LDL&#x002D;C</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>0.805</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>2.053</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.152</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>2.236</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.744&#x2013;6.723</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>UA</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>0.002</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>1.7</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.192</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>1.002</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.999&#x2013;1.006</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Diabetes</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>0.253</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>0.495</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.482</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>1.288</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.637&#x2013;2.605</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Gender</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>0.863</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>5.096</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.024</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>2.37</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>1.120&#x2013;5.015</SimplePara></entry></row><row><entry align="left" colname="c1"><SimplePara>Hypertension</SimplePara></entry><entry align="char" char="." colname="c2"><SimplePara>&#x002D;0.079</SimplePara></entry><entry align="char" char="." colname="c3"><SimplePara>0.048</SimplePara></entry><entry align="char" char="." colname="c4"><SimplePara>0.827</SimplePara></entry><entry align="char" char="." colname="c5"><SimplePara>0.924</SimplePara></entry><entry align="char" char="." colname="c6"><SimplePara>0.455&#x2013;1.876</SimplePara></entry></row></tbody></tgroup><tfooter><SimplePara>#the control group for ICAS group and NCAS group.</SimplePara><SimplePara><Emphasis Type="Bold">DISCUSSION</Emphasis></SimplePara></tfooter></Table></Para><Para ID="Par66"><UnorderedList Mark="Bullet"><ItemContent><Para ID="Par67">STENOSIS OF INTRACRANIAL AND EXTRACRANIAL ARTERIES IS NOT ONLY THE IMPORTANT PATHOPHYSIOLOGICAL BASIS OF STROKE BUT THE MOST COMMON ETIOLOGY OF STROKE<Superscript>[1] [2]</Superscript>.IN OUR STUDY, CEREBRAL ARTERY STENOSES MORE OFTEN HAPPENED IN OLD PEOPLE,ESPECIALLY INTRACRANIAL ARTERY STENOSES. THAT MAY EXPLAIN WHY MORE AND MORE PEOPLE SUFFER FROM STROKE WITH AGE.</Para></ItemContent><ItemContent><Para ID="Par68">URIC ACID IS THE METABOLIC END PRODUCT OF ENDOGENOUS AND EXOGENOUS PURINE METABOLISM, WHICH ARE THE MAJOR COMPONENTS OF RNA AND DNA<Superscript>[6]</Superscript>. ACCORDING A SURVEY UNDERTAKEN IN CHINA,10&#x0025; OF THE TOTAL POPULATION HAS HYPERURICAEMIA, WHICH ACCOUNTS FOR AROUND 120&#x00A0;MILLION PEOPLE<Superscript>[7]</Superscript>.The correlation between UA and cardiovascular disease is still disputed.It was once thought that UA was an antioxidative substance which could prevent arteriosclerosis<Superscript>[3]</Superscript>.But recently large prospective studies have demonstrated that hyperuricaemia was an independent risk factor of cerebral&#x002D;cardiovascular diseases. Some American scholars found that UA was an independent risk factor of myocardial infarction and stroke<Superscript>[8]</Superscript>.Sciacqua insisted that was an independent predictor of cardiovascular events in post&#x002D;menopausal women<Superscript>[4]</Superscript>.Some experts argued that hyperuricemia rose the risk of death and possibly increased the chance of relapse in stroke patients<Superscript>[9][10]</Superscript>.Few studies have reported on the relation&#x002D;ship between uric acid and intracranial and extracranial atherosclerosis stenosis. In this present study, hyperuricaemia was a risk factor for intracranial atherosclerosis stenosis in both the univariate and multivariate logistic regression analyses. The level of UA was higher in people who had more lesions of intracranial atherosclerosis stenosis.</Para></ItemContent></UnorderedList></Para><Tablefootnote>THE PATHOGENESIS OF HYPERURICAEMIA&#x002D;PROMOTING ARTERIOSCLEROSIS APPEARS TO BE CONSISTENT WITH STROKE: (I) URIC ACID PROMOTES LDL&#x002D;C OXIDATION AND LIPID PEROXIDATION,INDUCES VASCULAR ENDOTHELIAL CELL DYSFUNCTION, AND THE OXYGEN FREE RADICALS THAT ARE CREATED CAUSE AN INFLAMMATORY REACTION OF THE VASCULAR WALL THAT PROMOTES ATHEROSCLEROSIS<Superscript>[11]</Superscript>; (II)THE LEVEL OF URIC ACID IN THE BLOOD RISES AND THE EXCESS TURNS INTO CRYSTALS, TRIGGERING SEVERE INFLAMMATION IN VASCULAR WALLS<Superscript>[12]</Superscript>. SOME RESEARCH SHOW THAT THERE IS A LARGE AMOUNT OF URIC ACID CRYSTALS IN ATHEROSCLEROTIC PLAQUES<Superscript>[13]</Superscript>. (III) THE INFLAMMATORY REACTION CAUSED BY URIC ACID CRYSTALS ACTIVATES PLATELET FUNCTION, WHICH INCREASES PLATELET ADHESION AND STARTS THE COAGULATION CASCADE, WHICH ULTIMATELY PROMOTES THROMBOSIS<Superscript>[14]</Superscript>; (IV)URIC ACID CAUSES ENDOTHELIAL DYSFUNCTION, PROMOTES THE FORMATION OF LOCAL OXIDIZING AGENTS AND THE REACTION OF INFLAMMATORY MEDIATORS SUCH AS MONOCYTE CHEMOATTRACTANT PROTEIN,NUCLEAR FACTOR&#x002D;KB, INTERLEUKIN (IL)&#x002D;1B,IL&#x002D;6, AND TUMOUR NECROSIS FACTOR&#x002D;A<Superscript>[15]</Superscript><Subscript>;</Subscript> (V)ACTIVATION OF THE RENIN&#x002D;ANGIOTENSIN SYSTEM RELATED TO UA MAY ATTACK CEREBRAL CIRCULATION<Superscript>[16]</Superscript>.</Tablefootnote><Tablefootnote>IN OUR STUDY, UA WAS THE ONLY INDEPENDENT RISK FACTOR OF ICAS, NOT FOR ECAS.THE RESULTS PROVED THAT RISK FACTORS OF INTRACRANIAL AND EXTRACRANIAL ATHEROSCLEROSIS STENOSIS WERE DIFFERENT WHICH WAS CONSISTENT WITH LI<Superscript>[17]</Superscript>.</Tablefootnote><Tablefootnote>PREVIOUS RESEARCH OFTEN COMBINED THE INTRACRANIAL AND EXTRACRANIAL ARTERIES TO INVESTIGATE THE RISKS. BUT LANLLNEI<Superscript>[18]</Superscript> FOUND THAT ATHEROSCLEROTIC PLAQUES WERE DIFFERENT BETWEEN INTRACRANIAL AND EXTRACRANIAL ARTERIES FROM AUTOPSIES OF PATIENTS WITH CEREBRAL INFARCTION. INZITARI<Superscript>[19]</Superscript> INSISTED THAT THE RISKS OF INTRACRANIAL AND EXTRACRANIAL ATHEROSCLEROSIS STENOSIS WERE DIFFERENT, THE SAME TREATMENT MIGHT HAVE DIFFERENT RESULTS. COMPARED WITH NORMAL PEOPLE,SOME CLINICAL RESEARCH INDICATED THAT THERE WERE LESS ANTIOXIDANTS WHICH HAD THE FUNCTION CURE ATHEROSCLEROSIS IN SOME DEGREE IN INTRACRANIAL ARTERIES OF PATIENTS WITH STENO&#x002D;OCCLUSIVE INTRACRANIAL ARTERIES<Superscript>[20]</Superscript>.SO ANTIOXIDANTS WAS AN INDEPENDENT PROTECTIVE FACTOR OF INTRACRANIAL STENOSIS.MOREOVER, MANY STUDIES FOUND THAT LOW WALL SHEAR STRESS AND HYPERLIPEMIA WERE MAIN RISK HEMODYNAMIC FACTORS IN THE DEVELOPMENT OF ATHEROSCLEROTIC PLAQUE IN EXTRACRANIAL ARTERIES<Superscript>[21] [22]</Superscript>.</Tablefootnote><Tablefootnote>AS THE POPULATION WAS ALL HAN NATIONALITY, WE AVOIDED THE INFLUENCE OF ETHNIC VARIATION ON DISTRIBUTION OF STENOSIS OF INTRACRANIAL AND EXTRACRANIAL ARTERIES.THIS STUDY HAS SEVERAL LIMITATIONS: OUR DATA WERE OBTAINED IN A SINGLE CENTER, AND, ACCORDINGLY, AN EXTRAPOLATION OF OUR FINDINGS TO THE GENERAL CHINESE STROKE POPULATION OR OTHER ETHNIC POPULATIONS MIGHT BE LIMITED. WE COMPARED UA WITHIN ISCHEMIC STROKE POPULATION. IN THIS PRESENT STUDY, HYPERTENSION, AGE, DIABETES MELLITUS,LDL&#x002D;C AND TC WERE NOT INDEPENDENT RISK FACTORS FOR INTRACRANIAL STENOSIS OR EXTRACRANIAL STENOSIS, THAT WERE NOT CONSISTENT WITH THE RESULTS OF PREVIOUS STUDIES <Superscript>[23]</Superscript>. THIS RESULT MIGHT HAVE BEEN CAUSED BY THE SMALL SAMPLE SIZE AND THE CROSS&#x002D;SECTIONAL NATURE OF THE STUDY.SO A LARGER SAMPLE PROSPECTIVE MULTICENTER SURVEY WILL BE NEEDED IN HEALTHY POPULATION. AS WE CHOSE A RETROSPECTIVE STUDY, IT WAS UNAVOIDABLE TO BRING OUT THE SELECTION BIAS. BUT THE RELATIONSHIP OF UA AND STENOSIS OF INTRACRANIAL AND EXTRACRANIAL ARTERIES IS SIGNIFICANT FOR PREVENTION AND TREATMENT OF STROKE.</Tablefootnote><Bodyend></Bodyend></Section1><Ethics><Heading>Compliance with Ethical Standards:</Heading><FormalPara ID="FPar1" RenderingStyle="Style1"><Heading> ETHICAL APPROVAL:</Heading><Para ID="Par69"><UnorderedList Mark="Bullet"><ItemContent><Para ID="Par70">ALL PROCEDURES PERFORMED IN STUDIES INVOLVING HUMAN PARTICIPANTS WERE IN ACCORDANCE WITH THE ETHICAL STANDARDS OF THE THE ETHICS COMMITTEES OF:SECOND AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIVERSITY,QUANZHOU, FUJIAN PROVINCE, CHINA,AND WITH THE 1964 HELSINKI DECLARATION AND ITS LATER AMENDMENTS OR COMPARABLE ETHICAL STANDARDS.</Para></ItemContent></UnorderedList></Para></FormalPara></Ethics><Para ID="Par71"><UnorderedList Mark="Bullet"><ItemContent><Para ID="Par72"></Para></ItemContent></UnorderedList></Para><Bibliography ID="Bib1"><Heading>REFERENCES</Heading><Citation ID="CR1"><CitationNumber>1.</CitationNumber><BibArticle><BibAuthorName><Initials>IR</Initials><FamilyName>Wijngaard</FamilyName><Particle>Van den</Particle></BibAuthorName><BibAuthorName><Initials>G</Initials><FamilyName>Holswilder</FamilyName></BibAuthorName><BibAuthorName><Initials>MA</Initials><FamilyName>Walderveen</FamilyName><Particle>van</Particle></BibAuthorName><BibAuthorName><Initials>A</Initials><FamilyName>Algra</FamilyName></BibAuthorName><BibAuthorName><Initials>MJ</Initials><FamilyName>Wermer</FamilyName></BibAuthorName><BibAuthorName><Initials>OO</Initials><FamilyName>Zaidat</FamilyName></BibAuthorName><BibAuthorName><Initials>J</Initials><FamilyName>Boiten</FamilyName></BibAuthorName><Year>2016</Year><ArticleTitle Language="En">Treatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directions</ArticleTitle><JournalTitle>Brain Behav</JournalTitle><VolumeID>6</VolumeID><FirstPage>536</FirstPage></BibArticle><BibUnstructured><Annotation ID="6" Text="The citation for the reference: (Wijngaard et al. 2016) is missing. Please check" />Van den Wijngaard IR, Holswilder G, van Walderveen MA, Algra A, Wermer MJ, Zaidat OO, Boiten J (2016) Treatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directions. Brain Behav 6:536</BibUnstructured></Citation><Citation ID="CR2"><CitationNumber>2.</CitationNumber><BibArticle><BibAuthorName><Initials>Y</Initials><FamilyName>Xu</FamilyName></BibAuthorName><BibAuthorName><Initials>C</Initials><FamilyName>Yuan</FamilyName></BibAuthorName><BibAuthorName><Initials>Z</Initials><FamilyName>Zhou</FamilyName></BibAuthorName><BibAuthorName><Initials>L</Initials><FamilyName>He</FamilyName></BibAuthorName><BibAuthorName><Initials>D</Initials><FamilyName>Mi</FamilyName></BibAuthorName><BibAuthorName><Initials>R</Initials><FamilyName>Li</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Cui</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Wang</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Wang</FamilyName></BibAuthorName><BibAuthorName><Initials>G</Initials><FamilyName>Liu</FamilyName></BibAuthorName><BibAuthorName><Initials>Z</Initials><FamilyName>Zheng</FamilyName></BibAuthorName><BibAuthorName><Initials>X</Initials><FamilyName>Zhao</FamilyName></BibAuthorName><Year>2017</Year><ArticleTitle Language="En">Co&#x002D;existing intracranial and extracranial carotid artery atherosclerotic plaques and recurrent stroke risk: a three&#x002D;dimensional multicontrast cardiovascular magnetic resonance study</ArticleTitle><JournalTitle>J Cardiovasc Magn Reson</JournalTitle><VolumeID>18</VolumeID><FirstPage>90</FirstPage></BibArticle><BibUnstructured><Annotation ID="7" Text="The citation for the reference: (Xu et al. 2017) is missing. Please check" />Xu Y, Yuan C, Zhou Z, He L, Mi D, Li R, Cui Y, Wang Y, Wang Y, Liu G, Zheng Z, Zhao X (2017) Co&#x002D;existing intracranial and extracranial carotid artery atherosclerotic plaques and recurrent stroke risk: a three&#x002D;dimensional multicontrast cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 18:90</BibUnstructured></Citation><Citation ID="CR3"><CitationNumber>3.</CitationNumber><BibArticle><BibAuthorName><Initials>GK</Initials><FamilyName>Glantzounis</FamilyName></BibAuthorName><BibAuthorName><Initials>EC</Initials><FamilyName>Tsimoyiannis</FamilyName></BibAuthorName><BibAuthorName><Initials>AM</Initials><FamilyName>Kappas</FamilyName></BibAuthorName><BibAuthorName><Initials>DA</Initials><FamilyName>Galaris</FamilyName></BibAuthorName><Year>2005</Year><ArticleTitle Language="En">Uric acid and oxidative stress</ArticleTitle><JournalTitle>Curr Pharm Des</JournalTitle><VolumeID>11</VolumeID><FirstPage>4145</FirstPage><LastPage>4151</LastPage></BibArticle><BibUnstructured><Annotation ID="8" Text="The citation for the reference: (Glantzounis et al. 2005) is missing. Please check" />Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11:4145&#x2013;4151</BibUnstructured></Citation><Citation ID="CR4"><CitationNumber>4.</CitationNumber><BibArticle><BibAuthorName><Initials>A</Initials><FamilyName>Sciacqua</FamilyName></BibAuthorName><BibAuthorName><Initials>M</Initials><FamilyName>Perticone</FamilyName></BibAuthorName><BibAuthorName><Initials>EJ</Initials><FamilyName>Tassone</FamilyName></BibAuthorName><BibAuthorName><Initials>A</Initials><FamilyName>Cimellaro</FamilyName></BibAuthorName><BibAuthorName><Initials>S</Initials><FamilyName>Miceli</FamilyName></BibAuthorName><BibAuthorName><Initials>R</Initials><FamilyName>Maio</FamilyName></BibAuthorName><BibAuthorName><Initials>G</Initials><FamilyName>Sesti</FamilyName></BibAuthorName><Year>2015</Year><ArticleTitle Language="En">Perticone F.Uric acid is an independent predictor of cardiovascular events in post&#x002D;menopausal women</ArticleTitle><JournalTitle>Int J Cardiol</JournalTitle><VolumeID>197</VolumeID><FirstPage>271</FirstPage><LastPage>275</LastPage></BibArticle><BibUnstructured><Annotation ID="9" Text="The citation for the reference: (Sciacqua et al. 2015) is missing. Please check" />Sciacqua A, Perticone M, Tassone EJ, Cimellaro A, Miceli S, Maio R, Sesti G (2015) Perticone F.Uric acid is an independent predictor of cardiovascular events in post&#x002D;menopausal women. Int J Cardiol 197:271&#x2013;275</BibUnstructured></Citation><Citation ID="CR5"><CitationNumber>5.</CitationNumber><BibArticle><BibAuthorName><Initials>M</Initials><FamilyName>Liu</FamilyName></BibAuthorName><BibAuthorName><NoInitials /><FamilyName>Zhang</FamilyName></BibAuthorName><Year>2010</Year><ArticleTitle Language="En">SM,Rao ML;Cerebral vascular disease group of the Chinese Medical Association neurology branch.The 2010 Guidelines for the Chinese Diagnosis and Treatment of Acute Ischemic Stroke</ArticleTitle><JournalTitle>Chinese Journal of Neurology</JournalTitle><VolumeID>43</VolumeID><FirstPage>146</FirstPage><LastPage>153</LastPage></BibArticle><BibUnstructured><Annotation ID="10" Text="The citation for the reference: (Liu &amp; Zhang 2010) is missing. Please check" />Liu M, Zhang (2010) SM,Rao ML;Cerebral vascular disease group of the Chinese Medical Association neurology branch.The 2010 Guidelines for the Chinese Diagnosis and Treatment of Acute Ischemic Stroke. Chinese Journal of Neurology 43:146&#x2013;153</BibUnstructured></Citation><Citation ID="CR6"><CitationNumber>6.</CitationNumber><BibArticle><BibAuthorName><Initials>N</Initials><FamilyName>Logallo</FamilyName></BibAuthorName><BibAuthorName><Initials>H</Initials><FamilyName>Naess</FamilyName></BibAuthorName><BibAuthorName><Initials>TT</Initials><FamilyName>Idicula</FamilyName></BibAuthorName><BibAuthorName><Initials>J</Initials><FamilyName>Brogger</FamilyName></BibAuthorName><BibAuthorName><Initials>U</Initials><FamilyName>Waje&#x002D;Andreassen</FamilyName></BibAuthorName><BibAuthorName><Initials>L</Initials><FamilyName>Thomassen</FamilyName></BibAuthorName><Year>2011</Year><ArticleTitle Language="En">Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study</ArticleTitle><JournalTitle>BMC Neurol</JournalTitle><VolumeID>11</VolumeID><FirstPage>114</FirstPage></BibArticle><BibUnstructured><Annotation ID="11" Text="The citation for the reference: (Logallo et al. 2011) is missing. Please check" />Logallo N, Naess H, Idicula TT, Brogger J, Waje&#x002D;Andreassen U, Thomassen L (2011) Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study. BMC Neurol 11:114</BibUnstructured></Citation><Citation ID="CR7"><CitationNumber>7.</CitationNumber><BibArticle><BibAuthorName><Initials>YH</Initials><FamilyName>Huang</FamilyName></BibAuthorName><BibAuthorName><Initials>ST</Initials><FamilyName>Zhuo</FamilyName></BibAuthorName><BibAuthorName><Initials>YF</Initials><FamilyName>Chen</FamilyName></BibAuthorName><BibAuthorName><Initials>MM</Initials><FamilyName>Li</FamilyName></BibAuthorName><BibAuthorName><Initials>YY</Initials><FamilyName>Lin</FamilyName></BibAuthorName><BibAuthorName><Initials>ML</Initials><FamilyName>Yang</FamilyName></BibAuthorName><BibAuthorName><Initials>ZJ</Initials><FamilyName>Chen</FamilyName></BibAuthorName><BibAuthorName><Initials>RW</Initials><FamilyName>Cai</FamilyName></BibAuthorName><Year>2013</Year><ArticleTitle Language="En">Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator</ArticleTitle><JournalTitle>Chin Med J (Engl)</JournalTitle><VolumeID>126</VolumeID><FirstPage>4685</FirstPage><LastPage>4690</LastPage></BibArticle><BibUnstructured><Annotation ID="12" Text="The citation for the reference: (Huang et al. 2013) is missing. Please check" />Huang YH, Zhuo ST, Chen YF, Li MM, Lin YY, Yang ML, Chen ZJ, Cai RW (2013) Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator. Chin Med J (Engl) 126:4685&#x2013;4690</BibUnstructured></Citation><Citation ID="CR8"><CitationNumber>8.</CitationNumber><BibArticle><BibAuthorName><Initials>MJ</Initials><FamilyName>Bos</FamilyName></BibAuthorName><BibAuthorName><Initials>PJ</Initials><FamilyName>Koudstaal</FamilyName></BibAuthorName><BibAuthorName><Initials>A</Initials><FamilyName>Hofman</FamilyName></BibAuthorName><BibAuthorName><Initials>JC</Initials><FamilyName>Witteman</FamilyName></BibAuthorName><BibAuthorName><Initials>MM</Initials><FamilyName>Breteler</FamilyName></BibAuthorName><Year>2006</Year><ArticleTitle Language="En">Uric acid is a risk factor for myocardial infarction and stroke:the Rotterdam study</ArticleTitle><JournalTitle>Stroke</JournalTitle><VolumeID>37</VolumeID><FirstPage>1503</FirstPage><LastPage>1507</LastPage></BibArticle><BibUnstructured><Annotation ID="13" Text="The citation for the reference: (Bos et al. 2006) is missing. Please check" />Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM (2006) Uric acid is a risk factor for myocardial infarction and stroke:the Rotterdam study. Stroke 37:1503&#x2013;1507</BibUnstructured></Citation><Citation ID="CR9"><CitationNumber>9.</CitationNumber><BibArticle><BibAuthorName><Initials>Z</Initials><FamilyName>Wang</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Lin</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Liu</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Chen</FamilyName></BibAuthorName><BibAuthorName><Initials>B</Initials><FamilyName>Wang</FamilyName></BibAuthorName><BibAuthorName><Initials>C</Initials><FamilyName>Li</FamilyName></BibAuthorName><BibAuthorName><Initials>S</Initials><FamilyName>Yan</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Wang</FamilyName></BibAuthorName><BibAuthorName><Initials>W</Initials><FamilyName>Zhao</FamilyName></BibAuthorName><Year>2016</Year><ArticleTitle Language="En">Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke</ArticleTitle><JournalTitle>Mol Neurobiol</JournalTitle><VolumeID>53</VolumeID><FirstPage>1753</FirstPage><LastPage>1759</LastPage></BibArticle><BibUnstructured><Annotation ID="14" Text="The citation for the reference: (Wang et al. 2016) is missing. Please check" />Wang Z, Lin Y, Liu Y, Chen Y, Wang B, Li C, Yan S, Wang Y, Zhao W (2016) Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke. Mol Neurobiol 53:1753&#x2013;1759</BibUnstructured></Citation><Citation ID="CR10"><CitationNumber>10.</CitationNumber><BibArticle><BibAuthorName><Initials>KV</Initials><FamilyName>Charan Reddy</FamilyName></BibAuthorName><BibAuthorName><Initials>J</Initials><FamilyName>Ghanekar</FamilyName></BibAuthorName><BibAuthorName><Initials>KV</Initials><FamilyName>Charan Reddy</FamilyName></BibAuthorName><BibAuthorName><Initials>J</Initials><FamilyName>Ghanekar</FamilyName></BibAuthorName><Year>2014</Year><ArticleTitle Language="En">Prognostic Significance of Serum Uric Acid and Mortality Outcomes in Patients with Acute Cerebrovascular Ischemic Stroke</ArticleTitle><JournalTitle>International Journal of Stroke Research</JournalTitle><VolumeID>2</VolumeID><FirstPage>6</FirstPage><LastPage>14</LastPage></BibArticle><BibUnstructured><Annotation ID="15" Text="The citation for the reference: (Charan Reddy et al. 2014) is missing. Please check" />Charan Reddy KV, Ghanekar J, Charan Reddy KV, Ghanekar J (2014) Prognostic Significance of Serum Uric Acid and Mortality Outcomes in Patients with Acute Cerebrovascular Ischemic Stroke. International Journal of Stroke Research 2:6&#x2013;14</BibUnstructured></Citation><Citation ID="CR11"><CitationNumber>11.</CitationNumber><BibArticle><BibAuthorName><Initials>PM</Initials><FamilyName>Abuja</FamilyName></BibAuthorName><Year>1999</Year><ArticleTitle Language="En">Ascorbate prooxidant effects of urate in oxidation of human low density lipoprotein</ArticleTitle><JournalTitle>FEBS Lett</JournalTitle><VolumeID>446</VolumeID><FirstPage>305</FirstPage><LastPage>308</LastPage></BibArticle><BibUnstructured><Annotation ID="16" Text="The citation for the reference: (Abuja 1999) is missing. Please check" />Abuja PM (1999) Ascorbate prooxidant effects of urate in oxidation of human low density lipoprotein. FEBS Lett 446:305&#x2013;308</BibUnstructured></Citation><Citation ID="CR12"><CitationNumber>12.</CitationNumber><BibArticle><BibAuthorName><Initials>R</Initials><FamilyName>Kawamoto</FamilyName></BibAuthorName><BibAuthorName><Initials>H</Initials><FamilyName>Tomita</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Oka</FamilyName></BibAuthorName><BibAuthorName><Initials>A</Initials><FamilyName>Kodama</FamilyName></BibAuthorName><BibAuthorName><Initials>N</Initials><FamilyName>Ohtsuka</FamilyName></BibAuthorName><Year>2005</Year><ArticleTitle Language="En">Kamitani A.Association between uric acid and carotid Atherosclerosis in elderly persons</ArticleTitle><JournalTitle>Inter Med</JournalTitle><VolumeID>44</VolumeID><FirstPage>787</FirstPage><LastPage>793</LastPage></BibArticle><BibUnstructured><Annotation ID="17" Text="The citation for the reference: (Kawamoto et al. 2005) is missing. Please check" />Kawamoto R, Tomita H, Oka Y, Kodama A, Ohtsuka N (2005) Kamitani A.Association between uric acid and carotid Atherosclerosis in elderly persons. Inter Med 44:787&#x2013;793</BibUnstructured></Citation><Citation ID="CR13"><CitationNumber>13.</CitationNumber><BibArticle><BibAuthorName><Initials>C</Initials><FamilyName>Suarna</FamilyName></BibAuthorName><BibAuthorName><Initials>RT</Initials><FamilyName>Dean</FamilyName></BibAuthorName><BibAuthorName><Initials>J</Initials><FamilyName>May</FamilyName></BibAuthorName><BibAuthorName><Initials>R</Initials><FamilyName>Stocker</FamilyName></BibAuthorName><Year>1995</Year><ArticleTitle Language="En">Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha&#x002D;tocopherol and ascorbate</ArticleTitle><JournalTitle>Arterioscler Thromb Vasc Biol</JournalTitle><VolumeID>15</VolumeID><FirstPage>1616</FirstPage><LastPage>1624</LastPage></BibArticle><BibUnstructured><Annotation ID="18" Text="The citation for the reference: (Suarna et al. 1995) is missing. Please check" />Suarna C, Dean RT, May J, Stocker R (1995) Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha&#x002D;tocopherol and ascorbate. Arterioscler Thromb Vasc Biol 15:1616&#x2013;1624</BibUnstructured></Citation><Citation ID="CR14"><CitationNumber>14.</CitationNumber><BibArticle><BibAuthorName><Initials>J</Initials><FamilyName>Kanellis</FamilyName></BibAuthorName><BibAuthorName><Initials>DI</Initials><FamilyName>Feig</FamilyName></BibAuthorName><BibAuthorName><Initials>RJ</Initials><FamilyName>Johnson</FamilyName></BibAuthorName><Year>2004</Year><ArticleTitle Language="En">Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed</ArticleTitle><JournalTitle>Nephrology (Carlton)</JournalTitle><VolumeID>9</VolumeID><FirstPage>394</FirstPage><LastPage>399</LastPage></BibArticle><BibUnstructured><Annotation ID="19" Text="The citation for the reference: (Kanellis et al. 2004) is missing. Please check" />Kanellis J, Feig DI, Johnson RJ (2004) Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology (Carlton) 9:394&#x2013;399</BibUnstructured></Citation><Citation ID="CR15"><CitationNumber>15.</CitationNumber><BibArticle><BibAuthorName><Initials>DH</Initials><FamilyName>Kang</FamilyName></BibAuthorName><BibAuthorName><Initials>L</Initials><FamilyName>Han</FamilyName></BibAuthorName><BibAuthorName><Initials>X</Initials><FamilyName>Ouyang</FamilyName></BibAuthorName><BibAuthorName><Initials>AM</Initials><FamilyName>Kahn</FamilyName></BibAuthorName><BibAuthorName><Initials>J</Initials><FamilyName>Kanellis</FamilyName></BibAuthorName><BibAuthorName><Initials>P</Initials><FamilyName>Li</FamilyName></BibAuthorName><BibAuthorName><Initials>L</Initials><FamilyName>Feng</FamilyName></BibAuthorName><BibAuthorName><Initials>T</Initials><FamilyName>Nakagawa</FamilyName></BibAuthorName><BibAuthorName><Initials>S</Initials><FamilyName>Watanabe</FamilyName></BibAuthorName><BibAuthorName><Initials>M</Initials><FamilyName>Hosoyamada</FamilyName></BibAuthorName><BibAuthorName><Initials>H</Initials><FamilyName>Endou</FamilyName></BibAuthorName><BibAuthorName><Initials>M</Initials><FamilyName>Lipkowitz</FamilyName></BibAuthorName><BibAuthorName><Initials>R</Initials><FamilyName>Abramson</FamilyName></BibAuthorName><BibAuthorName><Initials>W</Initials><FamilyName>Mu</FamilyName></BibAuthorName><BibAuthorName><Initials>RJ</Initials><FamilyName>Johnson</FamilyName></BibAuthorName><Year>2005</Year><ArticleTitle Language="En">Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter</ArticleTitle><JournalTitle>Am J Nephrol</JournalTitle><VolumeID>25</VolumeID><FirstPage>425</FirstPage><LastPage>433</LastPage></BibArticle><BibUnstructured><Annotation ID="20" Text="The citation for the reference: (Kang et al. 2005) is missing. Please check" />Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, Feng L, Nakagawa T, Watanabe S, Hosoyamada M, Endou H, Lipkowitz M, Abramson R, Mu W, Johnson RJ (2005) Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 25:425&#x2013;433</BibUnstructured></Citation><Citation ID="CR16"><CitationNumber>16.</CitationNumber><BibArticle><BibAuthorName><Initials>M,HughesJ</Initials><FamilyName>Mazzali</FamilyName></BibAuthorName><BibAuthorName><Initials>YG</Initials><FamilyName>Kim</FamilyName></BibAuthorName><BibAuthorName><Initials>JA</Initials><FamilyName>Jefferson</FamilyName></BibAuthorName><BibAuthorName><Initials>DH</Initials><FamilyName>Kang</FamilyName></BibAuthorName><BibAuthorName><Initials>KL</Initials><FamilyName>Gordon</FamilyName></BibAuthorName><BibAuthorName><Initials>HY</Initials><FamilyName>Lan</FamilyName></BibAuthorName><BibAuthorName><Initials>S</Initials><FamilyName>Kivlighn</FamilyName></BibAuthorName><Year>2001</Year><ArticleTitle Language="En">Johnson RJ.Elevated uric acid increases blood pressure in the rat by a novel crystal&#x002D;independent</ArticleTitle><JournalTitle>mechanismHypertension</JournalTitle><VolumeID>38</VolumeID><FirstPage>1101</FirstPage><LastPage>1106</LastPage></BibArticle><BibUnstructured><Annotation ID="21" Text="The citation for the reference: (Mazzali et al. 2001) is missing. Please check" />Mazzali M,HughesJ, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S (2001) Johnson RJ.Elevated uric acid increases blood pressure in the rat by a novel crystal&#x002D;independent. mechanismHypertension 38:1101&#x2013;1106</BibUnstructured></Citation><Citation ID="CR17"><CitationNumber>17.</CitationNumber><BibArticle><BibAuthorName><Initials>MM</Initials><FamilyName>Li</FamilyName></BibAuthorName><BibAuthorName><Initials>YY</Initials><FamilyName>Lin</FamilyName></BibAuthorName><BibAuthorName><Initials>YH</Initials><FamilyName>Huang</FamilyName></BibAuthorName><BibAuthorName><Initials>ST</Initials><FamilyName>Zhuo</FamilyName></BibAuthorName><BibAuthorName><Initials>ML</Initials><FamilyName>Yang</FamilyName></BibAuthorName><BibAuthorName><Initials>HS</Initials><FamilyName>Lin</FamilyName></BibAuthorName><BibAuthorName><Initials>RW</Initials><FamilyName>Cai</FamilyName></BibAuthorName><Year>2015</Year><ArticleTitle Language="En">Association of Apolipoprotein A1, B with Stenosis of Intracranial and Extracranial Arteries in Patients with Cerebral Infarction</ArticleTitle><JournalTitle>Clinical Laboratory</JournalTitle><VolumeID>59</VolumeID><FirstPage>1727</FirstPage><LastPage>1735</LastPage></BibArticle><BibUnstructured><Annotation ID="22" Text="The citation for the reference: (Li et al. 2015) is missing. Please check" />Li MM, Lin YY, Huang YH, Zhuo ST, Yang ML, Lin HS, Cai RW (2015) Association of Apolipoprotein A1, B with Stenosis of Intracranial and Extracranial Arteries in Patients with Cerebral Infarction. Clinical Laboratory 59:1727&#x2013;1735</BibUnstructured></Citation><Citation ID="CR18"><CitationNumber>18.</CitationNumber><BibArticle><BibAuthorName><Initials>GA</Initials><FamilyName>Lammie</FamilyName></BibAuthorName><BibAuthorName><Initials>PA</Initials><FamilyName>Sandercock</FamilyName></BibAuthorName><BibAuthorName><Initials>MS</Initials><FamilyName>Dennis</FamilyName></BibAuthorName><Year>1999</Year><ArticleTitle Language="En">Recently occluded intracranial and extracranial carotid arteries. Relevance of the unstable atherosclerotic plaque</ArticleTitle><JournalTitle>Stroke</JournalTitle><VolumeID>30</VolumeID><FirstPage>1319</FirstPage><LastPage>1325</LastPage></BibArticle><BibUnstructured><Annotation ID="23" Text="The citation for the reference: (Lammie et al. 1999) is missing. Please check" />Lammie GA, Sandercock PA, Dennis MS (1999) Recently occluded intracranial and extracranial carotid arteries. Relevance of the unstable atherosclerotic plaque. Stroke 30:1319&#x2013;1325</BibUnstructured></Citation><Citation ID="CR19"><CitationNumber>19.</CitationNumber><BibArticle><BibAuthorName><Initials>D</Initials><FamilyName>Inzitari</FamilyName></BibAuthorName><BibAuthorName><Initials>VC</Initials><FamilyName>Hachinski</FamilyName></BibAuthorName><BibAuthorName><Initials>DW</Initials><FamilyName>Taylor</FamilyName></BibAuthorName><BibAuthorName><Initials>HJ</Initials><FamilyName>Barnett</FamilyName></BibAuthorName><Year>1990</Year><ArticleTitle Language="En">Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors?</ArticleTitle><JournalTitle>Arch Neurol</JournalTitle><VolumeID>47</VolumeID><FirstPage>1080</FirstPage><LastPage>1084</LastPage></BibArticle><BibUnstructured><Annotation ID="24" Text="The citation for the reference: (Inzitari et al. 1990) is missing. Please check" />Inzitari D, Hachinski VC, Taylor DW, Barnett HJ (1990) Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors? Arch Neurol 47:1080&#x2013;1084</BibUnstructured></Citation><Citation ID="CR20"><CitationNumber>20.</CitationNumber><BibArticle><BibAuthorName><Initials>FP1</Initials><FamilyName>D&#x2019;Armiento</FamilyName></BibAuthorName><BibAuthorName><Initials>A</Initials><FamilyName>Bianchi</FamilyName></BibAuthorName><BibAuthorName><Initials>F</Initials><FamilyName>Nigris</FamilyName><Particle>de</Particle></BibAuthorName><BibAuthorName><Initials>DM</Initials><FamilyName>Capuzzi</FamilyName></BibAuthorName><BibAuthorName><Initials>MR</Initials><FamilyName>D&#x2019;Armiento</FamilyName></BibAuthorName><BibAuthorName><Initials>G</Initials><FamilyName>Crimi</FamilyName></BibAuthorName><BibAuthorName><Initials>P</Initials><FamilyName>Abete</FamilyName></BibAuthorName><BibAuthorName><Initials>W</Initials><FamilyName>Palinski</FamilyName></BibAuthorName><BibAuthorName><Initials>M</Initials><FamilyName>Condorelli</FamilyName></BibAuthorName><BibAuthorName><Initials>C</Initials><FamilyName>Napoli</FamilyName></BibAuthorName><Year>2001</Year><ArticleTitle Language="En">Age&#x002D;related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis</ArticleTitle><JournalTitle>Stroke</JournalTitle><VolumeID>32</VolumeID><FirstPage>2472</FirstPage><LastPage>2479</LastPage></BibArticle><BibUnstructured><Annotation ID="25" Text="The citation for the reference: (D’Armiento et al. 2001) is missing. Please check" />D&#x2019;Armiento FP1, Bianchi A, de Nigris F, Capuzzi DM, D&#x2019;Armiento MR, Crimi G, Abete P, Palinski W, Condorelli M, Napoli C (2001) Age&#x002D;related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 32:2472&#x2013;2479</BibUnstructured></Citation><Citation ID="CR21"><CitationNumber>21.</CitationNumber><BibBook><BibAuthorName><Initials>AM</Initials><FamilyName>Malek</FamilyName></BibAuthorName><BibAuthorName><NoInitials /><FamilyName>Alper</FamilyName></BibAuthorName><Year>1999</Year><BookTitle>SL,Izumo S.Hemodynamic shear stress and its role in atherosclerosis.JAMA</BookTitle><NumberInSeries>282</NumberInSeries><FirstPage>2035</FirstPage><LastPage>2042</LastPage></BibBook><BibUnstructured><Annotation ID="26" Text="The citation for the reference: (Malek &amp; Alper 1999) is missing. Please check" />Malek AM, Alper SL,Izumo S.Hemodynamic shear stress and its role in atherosclerosis.JAMA 1999;282: 2035&#x2013;2042</BibUnstructured></Citation><Citation ID="CR22"><CitationNumber>22.</CitationNumber><BibArticle><BibAuthorName><Initials>Y</Initials><FamilyName>Wang</FamilyName></BibAuthorName><BibAuthorName><Initials>X</Initials><FamilyName>Zhao</FamilyName></BibAuthorName><BibAuthorName><Initials>L</Initials><FamilyName>Liu</FamilyName></BibAuthorName><BibAuthorName><Initials>YO</Initials><FamilyName>Soo</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Pu</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Pan</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Wang</FamilyName></BibAuthorName><BibAuthorName><Initials>X</Initials><FamilyName>Zou</FamilyName></BibAuthorName><BibAuthorName><Initials>TW</Initials><FamilyName>Leung</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Cai</FamilyName></BibAuthorName><BibAuthorName><Initials>Q</Initials><FamilyName>Bai</FamilyName></BibAuthorName><BibAuthorName><Initials>Y</Initials><FamilyName>Wu</FamilyName></BibAuthorName><BibAuthorName><Initials>C</Initials><FamilyName>Wang</FamilyName></BibAuthorName><BibAuthorName><Initials>X</Initials><FamilyName>Pan</FamilyName></BibAuthorName><BibAuthorName><Initials>B</Initials><FamilyName>Luo</FamilyName></BibAuthorName><BibAuthorName><Initials>KS</Initials><FamilyName>Wong</FamilyName></BibAuthorName><InstitutionalAuthorName>CICAS Study Group</InstitutionalAuthorName><Year>2014</Year><ArticleTitle Language="En">Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in China</ArticleTitle><JournalTitle>Stroke</JournalTitle><VolumeID>45</VolumeID><FirstPage>663</FirstPage><LastPage>669</LastPage></BibArticle><BibUnstructured><Annotation ID="27" Text="The citation for the reference: (Wang et al. 2014) is missing. Please check" />Wang Y, Zhao X, Liu L, Soo YO, Pu Y, Pan Y, Wang Y, Zou X, Leung TW, Cai Y, Bai Q, Wu Y, Wang C, Pan X, Luo B, Wong KS, CICAS Study Group (2014) Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in China. Stroke 45:663&#x2013;669</BibUnstructured></Citation><Citation ID="CR23"><CitationNumber>23.</CitationNumber><BibArticle><BibAuthorName><Initials>MJ</Initials><FamilyName>O&#x2019;Donnell</FamilyName></BibAuthorName><BibAuthorName><Initials>D</Initials><FamilyName>Xavier</FamilyName></BibAuthorName><BibAuthorName><Initials>L</Initials><FamilyName>Liu</FamilyName></BibAuthorName><BibAuthorName><Initials>H</Initials><FamilyName>Zhang</FamilyName></BibAuthorName><BibAuthorName><Initials>SL</Initials><FamilyName>Chin</FamilyName></BibAuthorName><BibAuthorName><Initials>P</Initials><FamilyName>Rao&#x002D;Melacini</FamilyName></BibAuthorName><BibAuthorName><Initials>S</Initials><FamilyName>Rangarajan</FamilyName></BibAuthorName><BibAuthorName><Initials>S</Initials><FamilyName>Islam</FamilyName></BibAuthorName><BibAuthorName><Initials>P</Initials><FamilyName>Pais</FamilyName></BibAuthorName><BibAuthorName><Initials>MJ</Initials><FamilyName>McQueen</FamilyName></BibAuthorName><BibAuthorName><Initials>C</Initials><FamilyName>Mondo</FamilyName></BibAuthorName><BibAuthorName><Initials>A</Initials><FamilyName>Damasceno</FamilyName></BibAuthorName><BibAuthorName><Initials>P</Initials><FamilyName>Lopez&#x002D;Jaramillo</FamilyName></BibAuthorName><BibAuthorName><Initials>GJ</Initials><FamilyName>Hankey</FamilyName></BibAuthorName><BibAuthorName><Initials>AL</Initials><FamilyName>Dans</FamilyName></BibAuthorName><BibAuthorName><Initials>K</Initials><FamilyName>Yusoff</FamilyName></BibAuthorName><BibAuthorName><Initials>T</Initials><FamilyName>Truelsen</FamilyName></BibAuthorName><BibAuthorName><Initials>HC</Initials><FamilyName>Diener</FamilyName></BibAuthorName><BibAuthorName><Initials>RL</Initials><FamilyName>Sacco</FamilyName></BibAuthorName><BibAuthorName><Initials>D</Initials><FamilyName>Ryglewicz</FamilyName></BibAuthorName><BibAuthorName><Initials>A</Initials><FamilyName>Czlonkowska</FamilyName></BibAuthorName><BibAuthorName><Initials>C</Initials><FamilyName>Weimar</FamilyName></BibAuthorName><BibAuthorName><Initials>X</Initials><FamilyName>Wang</FamilyName></BibAuthorName><BibAuthorName><Initials>S</Initials><FamilyName>Yusuf</FamilyName></BibAuthorName><Year>2010</Year><ArticleTitle Language="En">INTERSTROKE investigators.Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case&#x002D;control study</ArticleTitle><VolumeID>376</VolumeID><FirstPage>112</FirstPage><LastPage>123</LastPage></BibArticle><BibUnstructured><Annotation ID="28" Text="The citation for the reference: (O’Donnell et al. 2010) is missing. Please check" />O&#x2019;Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao&#x002D;Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez&#x002D;Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S; INTERSTROKE investigators.Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case&#x002D;control study.Lancet 2010;376:112&#x2013;123</BibUnstructured></Citation></Bibliography></Article>